1. Estradiol increases IRS-1 gene expression and insulin signaling in breast cancer cells.
- Author
-
Mauro L, Salerno M, Panno ML, Bellizzi D, Sisci D, Miglietta A, Surmacz E, and Andò S
- Subjects
- Analysis of Variance, Breast Neoplasms, Humans, Insulin Receptor Substrate Proteins, Phosphoproteins genetics, Phosphorylation, Promoter Regions, Genetic genetics, RNA, Messenger drug effects, RNA, Messenger metabolism, Signal Transduction drug effects, Signal Transduction physiology, Tumor Cells, Cultured, Tyrosine metabolism, Estradiol pharmacology, Gene Expression Regulation drug effects, Insulin physiology, Phosphoproteins metabolism, Promoter Regions, Genetic drug effects
- Abstract
This study demonstrates how the potentiating effects of E2 on insulin signaling in ER-positive breast cancer cells are consequent to an enhanced IRS-1 expression [corrected]. It induces an increase of both PI-3K/AKT and ERK1/2 activities. A direct action of E2 in the regulating mouse IRS-1 gene is also investigated in both Chinese hamster ovary and MCF-7 cells that are transfected with mouse IRS-1 regulatory sequences. The authors have reported, for the first time, how E2 induction of IRS-1 mRNA was correlated with a direct positive regulatory role of E2 on the IRS-1 promoter. This effect seems to be not strictly related to the cell type., (Copyright 2001 Academic Press.)
- Published
- 2001
- Full Text
- View/download PDF